CLINICAL PHARMACOLOGY CONSULTATION AND OUTCOMES ASSOCIATED WITH PREGNANCY EXPOSURE TO FDA CATEGORY X DRUGS

被引:0
|
作者
Turk, Erdeljic, V
Francetic, I
Ksenija, M.
Matea, R.
Robert, L.
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
200
引用
收藏
页码:63 / 63
页数:1
相关论文
共 50 条
  • [41] Vedolizumab exposure in pregnancy: Outcomes from clinical studies in inflammatory bowel disease
    Dubinsky, M.
    Mahadevan, U.
    Vermeire, S.
    Abhyankar, B.
    Lasch, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S361 - S362
  • [42] Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
    Mahadevan, U.
    Vermeire, S.
    Lasch, K.
    Abhyankar, B.
    Bhayat, F.
    Blake, A.
    Dubinsky, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 941 - 950
  • [43] Evolving oncology clinical pharmacology strategies oncology: An analysis of approved small molecule cancer drugs by the FDA 2011-2016.
    Masson, Eric
    Reeves, Matthew
    Rabbie, Sarit
    Carlie, David J.
    Tomkinson, Helen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Differences in clinical presentation and outcomes in pregnancy-associated Takotsubo Syndrome- A scoping review of the literature Outcomes in pregnancy-associated Takotsubo
    Udemgba, Chinelo
    Bravo-Jaimes, Katia
    Mejia, Miluska O.
    Oli, Prakash Raj
    Shrestha, Dhan Bahadur
    Dawadi, Sagun
    Kadariya, Dinesh
    Velarde, Gladys
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
  • [45] Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes
    Kwah, Jason H.
    Burn, Martina S.
    Liao, Jane
    Cate, Jennifer
    Son, Moeun
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2022, 4 (05)
  • [46] Evaluation of Drugs Exposure in Pregnancy According to Different Risk Categories: Do FDA-Based Decisions Lead to More Curettage?
    Demir, Omer
    Arici, M. Aylin
    Demiral, Yucel
    Tuncok, Yesim
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (04): : 901 - 909
  • [47] Major Congenital Malformations Associated With Exposure to Second-Generation Antipsychotic Drugs During Pregnancy
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (05)
  • [48] Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes An Investigation of the Regulator in Japan
    Sato, Ryosuke
    Ikuma, Mutsuhiro
    Takagi, Kazunori
    Yamagishi, Yoshiaki
    Asano, Junichi
    Matsunaga, Yusuke
    Watanabe, Hiroshi
    MEDICINE, 2015, 94 (01) : e386
  • [49] A RENEWED LOOK AT OCCUPATIONAL EXPOSURE TO ANTINEOPLASTIC DRUGS AND PREGNANCY OUTCOMES: RESULTS OF A SYSTEMATIC REVIEW OF THE LITERATURE.
    Martin, K. Ashley
    ONCOLOGY NURSING FORUM, 2010, 37 (03) : E263 - E263
  • [50] PREGNANCY OUTCOMES AFTER MATERNAL OR PATERNAL EXPOSURE IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Mahadevan, Uma
    Chaparro, Maria
    Segovia, Michelle
    Kulisek, Nicole
    Guo, Xiang
    Wu, Joseph
    Vranic, Ivana
    Diehl, Annette
    Dubinsky, Marla C.
    GASTROENTEROLOGY, 2024, 166 (05) : S171 - S171